The 36-month beta value for CLMT is also noteworthy at 1.85. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 1 rating it as “sell.”
The public float for CLMT is 68.93M, and at present, short sellers hold a 10.91% of that float. The average trading volume of CLMT on February 20, 2025 was 1.10M shares.
CLMT) stock’s latest price update
Calumet Inc (NASDAQ: CLMT) has experienced a decline in its stock price by -2.46 compared to its previous closing price of 15.47. However, the company has seen a fall of -13.33% in its stock price over the last five trading days. prnewswire.com reported 2025-02-19 that INDIANAPOLIS, Feb. 19, 2025 /PRNewswire/ — Calumet, Inc. (NASDAQ: CLMT) (“Calumet”) announced today plans to attend the Raymond James Institutional Investors Conference on Tuesday, March 4, 2025, in Orlando, Florida. Calumet will be holding one-on-one investor meetings throughout the day at the conference.
CLMT’s Market Performance
Calumet Inc (CLMT) has seen a -13.33% fall in stock performance for the week, with a -5.92% decline in the past month and a -27.87% plunge in the past quarter. The volatility ratio for the week is 8.01%, and the volatility levels for the past 30 days are at 8.21% for CLMT. The simple moving average for the past 20 days is -8.31% for CLMT’s stock, with a -15.82% simple moving average for the past 200 days.
Analysts’ Opinion of CLMT
Many brokerage firms have already submitted their reports for CLMT stocks, with UBS repeating the rating for CLMT by listing it as a “Sell.” The predicted price for CLMT in the upcoming period, according to UBS is $15 based on the research report published on February 04, 2025 of the current year 2025.
TD Cowen, on the other hand, stated in their research note that they expect to see CLMT reach a price target of $26, previously predicting the price at $27. The rating they have provided for CLMT stocks is “Buy” according to the report published on November 11th, 2024.
TD Cowen gave a rating of “Buy” to CLMT, setting the target price at $27 in the report published on October 17th of the previous year.
CLMT Trading at -20.53% from the 50-Day Moving Average
After a stumble in the market that brought CLMT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.33% of loss for the given period.
Volatility was left at 8.21%, however, over the last 30 days, the volatility rate increased by 8.01%, as shares sank -5.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.90% lower at present.
During the last 5 trading sessions, CLMT fell by -13.56%, which changed the moving average for the period of 200-days by -5.52% in comparison to the 20-day moving average, which settled at $16.45. In addition, Calumet Inc saw -31.47% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLMT starting from Straumins Jennifer, who sale 37,861 shares at the price of $21.42 back on Dec 18 ’24. After this action, Straumins Jennifer now owns 1,184,589 shares of Calumet Inc, valued at $810,983 using the latest closing price.
Straumins Jennifer, the Director of Calumet Inc, proposed sale 50,000 shares at $21.50 during a trade that took place back on Dec 18 ’24, which means that Straumins Jennifer is holding shares at $1,075,000 based on the most recent closing price.
Stock Fundamentals for CLMT
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.05 for the gross margin
The net margin for Calumet Inc stands at -0.05. The total capital return value is set at -0.0.
Based on Calumet Inc (CLMT), the company’s capital structure generated 1.48 points at debt to capital in total, while cash flow to debt ratio is standing at -0.02. The debt to equity ratio resting at -3.06. The interest coverage ratio of the stock is -0.01.
Currently, EBITDA for the company is 418.2 million with net debt to EBITDA at 12.96. When we switch over and look at the enterprise to sales, we see a ratio of 0.79. The receivables turnover for the company is 13.8for trailing twelve months and the total asset turnover is 1.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.63.
Conclusion
In summary, Calumet Inc (CLMT) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
